Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria R Parkhurst

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Cancer Immunology, Immunotherapy : CII|June 19, 2025
Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancersAlexandra M Gustafson, Aaron J Dinerman, Kyle J Hitscherich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
The Journal of Clinical Investigation|October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesAlena Gros, Eric Tran, Maria R Parkhurst, et al.
The Journal of Clinical Investigation|October 5, 2020
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancerGal Cafri, Jared J Gartner, Tal Zaks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous MelanomaPaul H McClelland, Shirley K Nah, Alexandra M Gustafson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Cancer Immunology, Immunotherapy : CII|June 19, 2025
Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancersAlexandra M Gustafson, Aaron J Dinerman, Kyle J Hitscherich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
The Journal of Clinical Investigation|October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesAlena Gros, Eric Tran, Maria R Parkhurst, et al.
The Journal of Clinical Investigation|October 5, 2020
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancerGal Cafri, Jared J Gartner, Tal Zaks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous MelanomaPaul H McClelland, Shirley K Nah, Alexandra M Gustafson, et al.
Pageof 4